Shelf life – Page 46

Common Stability Study Design Mistakes in Long-Term and Accelerated Studies

Identifying and Resolving Common Errors in Stability Study Design In the rapidly evolving pharmaceutical landscape, the integrity of stability studies is paramount. Even minor missteps in stability study design, such…

How to Align Stability Protocols with ICH Q1A(R2) Requirements

Strategies to Align Stability Protocols with ICH Q1A(R2) Framework In the pharmaceutical industry, ensuring compliance with regulatory expectations for stability studies is paramount. Stability protocols must align with guidelines such…

How to Investigate Unexpected Assay Loss During Photostability Testing

Effective Steps to Investigate Unexpected Assay Loss in Photostability Testing Unexpected assay loss during photostability testing can disrupt pharmaceutical stability studies and compromise regulatory compliance. This article outlines practical steps…

How Poor Stability Protocol Design Creates Shelf-Life Rejection Risk

Identifying and Addressing Stability Study Design Errors to Mitigate Shelf-Life Rejection Risks In pharmaceutical manufacturing, the integrity of stability studies is crucial to ensuring product safety and efficacy over its…

FDA and EMA Expectations for Stability Data in New Drug Submissions

Understanding and Meeting Regulatory Expectations for Stability Studies in Drug Submissions In the pharmaceutical industry, regulatory expectations for stability studies represent a critical aspect of ensuring drug quality and efficacy.…

Why Photostability Studies Fail Despite Following ICH Q1B Exposure Conditions

Troubleshooting Photostability Study Failures in Compliance with ICH Q1B In the pharmaceutical industry, the integrity and efficacy of drug products are crucial, and photostability studies serve as a benchmark for…

Why Photostability Studies Fail Despite Following ICH Q1B Exposure Conditions

Addressing Photostability Study Failures: Recommendations for Compliance and Quality Assurance In the realm of pharmaceutical manufacturing, ensuring the quality and stability of products is paramount. One common challenge that arises…

Stability Study Design Errors That Lead to FDA Questions During Review

Mistakes in Stability Study Design That Trigger FDA Inquiries Stability studies are critical in demonstrating the shelf-life and quality of pharmaceutical products. Errors in designing these studies can lead to…

Stability Study Design Errors That Lead to FDA Questions During Review

Addressing Common Errors in Stability Study Design for FDA Review Stability study design errors can create significant challenges in pharmaceutical manufacturing, particularly when submitted data raises concerns during FDA review.…

Improper Storage Reducing Material Shelf Life? Storage Control and Monitoring Solutions

Addressing Improper Storage Impacting Material Shelf Life: Effective Storage Control and Monitoring Strategies In pharmaceutical manufacturing, the proper storage of raw materials is crucial for maintaining their integrity and ensuring…

Stability Failures and OOT? Stability Program Solutions

Addressing Stability Study Failures and OOT Signals: Practical Solutions Stability studies are pivotal in ensuring the quality and shelf life of pharmaceutical products. However, encountering out-of-trend (OOT) results or outright…

Stability Failures and OOT Trends? Shelf-Life Management Solutions From Protocol to CAPA

Managing Stability Failures and OOT Trends Through Effective Shelf-Life Strategies In the pharmaceutical industry, stability failures and out-of-trend (OOT) excursions can pose significant challenges to product integrity and compliance. When…